ChartRow logo
Sign in
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Stock · Health Care
$17.41+$0.00 (+0.00%)as of market close, Aug 13, 2026
☾ After hours:$17.39+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

How Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) makes money

Period

How does Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · FY2026 · year ended 2026-03-31
Revenue$29.8BNet loss$941M · 3%Cost of revenue$10.4B · 35%Gross profit$19.4B · 65%Operating expenses$19.4B · 65%R&D$4.5B · 15%Other opex$14.9B · 50%Other expense$941M · 3%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.